West Pharmaceutical Services Net Change in Cash and Restricted Cash decreased by 327.2% to -$269.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 235.7%, from -$80.40M to -$269.90M. This decline may warrant attention — for this metric, higher values are generally preferred.
A positive change indicates net cash generation, while a negative change indicates net cash consumption.
This represents the total net increase or decrease in the company's cash, cash equivalents, and restricted cash balances...
A standard liquidity metric found in the statement of cash flows for all public companies.
cvx_net_change_in_cash_and_restricted_cash| Q3 '21 | Q1 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $111.80M | -$94.90M | -$8.00M | -$90.00M | $102.30M | -$252.10M | -$155.60M | -$80.40M | $105.50M | $118.80M | -$269.90M |
| QoQ Change | — | -184.9% | +91.6% | <-999% | +213.7% | -346.4% | +38.3% | +48.3% | +231.2% | +12.6% | -327.2% |
| YoY Change | — | — | +91.6% | — | — | <-999% | -72.9% | +68.1% | +167.8% | — | -235.7% |